Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Peptides. 2020 Jul 13;131:170369. doi: 10.1016/j.peptides.2020.170369

Figure 24. Glycopeptides Related to Morphiceptin.

Figure 24.

Morphiceptin glycopeptides containing either glucosylated or galactosylated hydroxyproline moieties were less potent than morphine in vivo. Interestingly, this is the opposite result of incorporating a carbohydrate moiety into opioid peptides. This indicates that morphiceptin adopts a different bioactive conformation than opioid peptides do. (Valencia 1990) [123].